STOCK TITAN

Greenpro Capital Corp. 8-K Filings

GRNQ NASDAQ

Every 8-K that Greenpro Capital Corp. (GRNQ) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow GRNQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRNQ filings page.

Rhea-AI Summary

Greenpro Capital Corp. is implementing a 1-for-10 reverse stock split of its common stock. A certificate of amendment filed in Nevada becomes effective at 9:00 p.m. Pacific Time on August 4, 2026, and the shares will begin trading on a split-adjusted basis on The Nasdaq Capital Market on August 6, 2026 under the symbol GRNQ with new CUSIP 39540F408.

Each ten shares outstanding immediately before the effective time will automatically be combined into one share, with fractional positions rounded up to the nearest whole share. Based on 18,127,663 shares outstanding as of June 30, 2026, the split would reduce outstanding shares to approximately 1,812,786, without changing the $0.0001 par value or authorized share counts. The company states the action is primarily intended to increase its per share trading price and notes ongoing strategic initiatives, including an application for a digital banking license under the Malaysia Labuan Financial Services Authority framework.

Rhea-AI Summary

Greenpro Capital Corp. entered into a subscription agreement with its CEO, President and Director, Mr. Lee Chong Kuang, for a private placement of 65,591 common shares at $1.5246 per share, raising aggregate gross proceeds of $100,000. The offering closed on June 30, 2026 and was conducted without underwriters.

After this transaction, the company had 18,127,663 common shares issued and outstanding. Mr. Lee directly held 1,940,884 shares, or 10.71% of the outstanding stock, and together with his spouse, Ms. Yap Pei Ling, they held 2,106,799 shares, representing approximately 11.62% of the company’s common stock. The proceeds are planned to be used for operating capital.

Rhea-AI Summary

Greenpro Capital Corp. entered into a Confidential Settlement Agreement and Mutual Release of Claims with Millennium Fine Art Inc. to resolve a Nevada state court case and related arbitration tied to an alleged 2021 NFT-related contract. Subject to closing conditions, Greenpro will pay $100,000 and surrender 2,000,000 restricted shares of MFAI Class B common stock for cancellation, which equals its entire equity interest in MFAI and represents about 5% of MFAI’s issued and outstanding shares and about 1% of its total voting rights. After the settlement consideration is exchanged, all litigation and arbitration will be dismissed with prejudice, and both parties grant mutual general releases, with no admission of liability or wrongdoing. The Board approved the settlement by unanimous written consent dated June 15, 2026.

Rhea-AI Summary

Greenpro Capital Corp. approved a 1-for-10 reverse stock split of its common stock. The move was authorized on June 18, 2026 by written consent of holders of 11,012,377 voting shares, representing approximately 60.97% of the company’s voting power, without holding a stockholder meeting.

The company intends to complete the reverse split on or about July 26, 2026, after mailing a Schedule 14C information statement and filing an appropriate certificate in Nevada. Every 10 issued and outstanding common shares will be combined into 1 share, with no change to the terms of the stock.

No fractional shares will be issued; any fractional entitlement will be rounded up to the nearest whole share. The split will not change individual ownership percentages except for this rounding. Authorized shares will not be reduced, increasing the number of authorized but unissued shares, which the company notes could have a potential anti-takeover effect.

Rhea-AI Summary

Greenpro Capital Corp. entered into a Subscription Agreement with its Chief Executive Officer, President and Director, Mr. Lee Chong Kuang, for a private placement of 28,949 shares of common stock at $1.7272 per share, generating $50,000 in gross proceeds. The offering closed on May 29, 2026 and the company plans to use the cash for operating capital.

After this issuance, Greenpro had 18,062,072 common shares outstanding. Mr. Lee directly owned 1,875,293 shares, or 10.38% of the company, and together with his spouse held 2,041,208 shares, representing about 11.3% of outstanding stock. The shares were issued as unregistered securities under Section 4(a)(2), Regulation D and/or Regulation S.

Rhea-AI Summary

Greenpro Capital Corp. entered into a Subscription Agreement with its CEO, President and Director, Mr. Lee Chong Kuang, for a private placement of 107,310 shares of common stock at $2.3297 per share, raising gross proceeds of $250,000.

The offering closed on April 28, 2026 and increased total common shares issued and outstanding to 18,033,123. After the transaction, Mr. Lee directly holds 1,846,344 shares, or 10.24% of the company, and together with his spouse holds 2,012,259 shares, or about 11.16%. The company plans to use the proceeds for operating capital. The shares were issued as unregistered securities under exemptions including Section 4(a)(2), Regulation D and Regulation S.

Rhea-AI Summary

Greenpro Capital Corp. reported a leadership change on its Board of Directors. Christopher Yu Nien Wong has notified the company that he will resign as a director effective April 30, 2026. He will also step down from the Audit, Compensation, and Nominating and Corporate Governance Committees on that date.

The company states that Mr. Wong’s resignation is not due to any disagreement regarding its operations, policies, or practices. Greenpro Capital is currently evaluating candidates to fill the resulting Board vacancy.

Rhea-AI Summary

Greenpro Capital Corp. entered into and closed a small equity acquisition tied to a share issuance. On November 18, 2025, the company agreed to acquire 0.99% of Greenophene Technologies Limited (10 ordinary shares). On April 16, 2026, closing occurred and Greenpro issued 800,000 restricted common shares at $1.50 per share, valuing the consideration at $1,200,000. The shares were issued privately under Rule 506 of Regulation D as “restricted securities” under Rule 144. After the transaction, Greenpro had 17,925,813 common shares outstanding, and the seller held approximately 4.5% of the company’s common stock.

Rhea-AI Summary

Greenpro Capital Corp. completed a share exchange, issuing 8,500,000 shares of common stock to Forekast Limited shareholders for a 13.6% minority stake in Forekast as of March 31, 2026. The company received 1,360 Forekast ordinary shares and did not obtain control of Forekast.

This equity issuance increased Greenpro’s common shares outstanding from 8,625,813 on March 30, 2026 to 17,125,813 on the closing date, significantly diluting existing holders. New large shareholders include BHL Ltd. with 3,250,000 shares (18.98% of outstanding) and several other entities each holding 1,125,000 shares (6.57% each).

Rhea-AI Summary

Greenpro Capital Corp. signed a Share Exchange Agreement to acquire a 13.6% fully diluted equity interest in Forekast Limited. In return, Greenpro will issue 8,500,000 shares of its common stock to Forekast’s shareholders at closing, subject to customary conditions and an outside closing date of March 31, 2026.

Rhea-AI Summary

Greenpro Capital Corp. disclosed that it entered into a Subscription Agreement on December 18, 2025 for a private placement of 100,000 shares of its common stock at $1.50 per share, raising aggregate gross proceeds of $150,000. The transaction closed the same day and involves newly issued common stock with a par value of $0.0001 per share.

The company relied on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D and/or Regulation S, with purchasers representing that they are accredited investors or non‑U.S. persons. No underwriters participated, and Greenpro Capital plans to use the proceeds for operating capital.

Rhea-AI Summary

Greenpro Capital Corp. disclosed an agreement to acquire a 0.99% equity stake in Greenophene Technologies Limited from an individual seller. In return, Greenpro will issue 800,000 shares of its common stock, valuing the transaction at US$1,200,000, or US$1.50 per share.

The 800,000 shares will be issued as restricted securities under Rule 144 and are being offered in a private placement relying on Rule 506 of Regulation D. All of these shares will be held in escrow and remain under the Company’s control until the closing of the acquisition, which is subject to customary conditions, representations, warranties, and securities law compliance by both parties.

Rhea-AI Summary

Greenpro Capital Corp. (GRNQ) reported a small private stock financing. On November 14, 2025, the company sold 150,000 shares of common stock at $1.30 per share in a private placement to accredited individual investors, generating $195,000 in gross proceeds. The transaction was completed under Regulation D and Section 4(a)(2) of the Securities Act, meaning the shares were issued without SEC registration. No underwriters were involved, and the company plans to use the cash raised for operating capital.

Rhea-AI Summary

Greenpro Capital Corp. entered into subscription agreements with individual accredited investors for a private placement of 100,000 shares of its common stock at $1.30 per share. The offering, which closed on October 1, 2025, was conducted without underwriters and relied on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation D.

The company states that each purchaser represented being an accredited investor, supporting the use of the private offering exemptions. Greenpro plans to use the cash raised for operating capital, providing additional funds to support its ongoing business needs.

Rhea-AI Summary

Greenpro Capital Corp. reported a change in its independent registered public accounting firm. On September 10, 2025, the board and audit committee accepted the resignation of JP Centurion & Partners PLT as auditor, effective immediately. JP Centurion’s reports on the company’s financial statements for the years ended December 31, 2024 and 2023 contained no adverse or disclaimed opinions and were not qualified, other than explanatory paragraphs about the company’s ability to continue as a going concern and critical audit matters.

The company states there were no disagreements with JP Centurion and no reportable events during those periods or the subsequent interim period. The board and audit committee approved the engagement of SFAI Malaysia PLT as the new independent auditor for the fiscal year ending December 31, 2025 and related interim periods. Greenpro Capital has requested a letter from JP Centurion addressed to the SEC regarding these disclosures and is liaising with the firm to obtain it.

Rhea-AI Summary

Greenpro Capital Corp (NASDAQ: GRNQ) has completed a private placement offering on June 23, 2025, raising capital through the sale of 200,000 shares of common stock at $1.30 per share, totaling $260,000.

Key details of the transaction:

  • The shares were issued under Section 4(a)(2) of the Securities Act and Regulation D exemptions
  • The purchaser qualified as an "accredited investor" under Rule 501(a)
  • No underwriters were involved in the transaction
  • Proceeds will be used for operating capital

The private placement was executed through a subscription agreement with an individual investor. The company's common stock is listed on the NASDAQ Capital Market. The transaction represents a strategic move to strengthen the company's working capital position through equity financing.